Low-energy fractures of the humeral shaft and bisphosphonate use
Open Access
- 9 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 27 (6) , 1425-1431
Abstract
Atypical fractures of the femur have been reported to occur in patients on long-term treatment with bisphosphonates; however, causality has not been proven, and it is not known whether similar fractures may occur in other long bones. We addressed this issue by examining the relationship between humeral shaft fractures and bisphosphonate use. We identified all patients aged ≥50 years consecutively admitted to a single center with a new fracture of the humerus. All individual radiographs were examined and fracture site was classified. A case-control study was undertaken in patients with humeral shaft fractures, and controls were sex- and age-matched patients with proximal humeral fractures in a 1:4 ratio. Patients with shaft fractures and radiographic characteristics similar to those of atypical femoral fractures were compared with those with ordinary shaft fractures. The association between “atypical” fractures and bisphosphonate or glucocorticoid use was examined. A total of 198 patients had a low-energy fracture of the humerus; 20 of these patients had a shaft fracture (10%). These 20 patients (cases) were matched with 80 patients with proximal fractures (controls). Bisphosphonates were used by 5% of cases and by 6.3% of controls (odds ratio [OR], 0.80; 95% confidence interval [CI], 0.09–6.85); glucocorticoids were used by 10% of cases and 8.8% of controls (OR, 1.15; 95% CI, 0.23–5.83). There was no difference in cortical thickness between cases and controls and bisphosphonate or glucocorticoid users and nonusers. Four of the 20 patients with shaft fractures had “atypical” radiographic features, with significantly increased cortical thickness, but none of these had ever been treated with bisphosphonates or glucocorticoids. Our results show that low-energy fractures of the humeral shaft with “atypical” radiographic characteristics are infrequent and are not associated with the use of bisphosphonates or glucocorticoids. © 2012 American Society for Bone and Mineral Research.Keywords
This publication has 28 references indexed in Scilit:
- Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and featuresBone, 2011
- Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportOsteoporosis International, 2010
- Unusual mid‐shaft fractures during long‐term bisphosphonate therapyClinical Endocrinology, 2010
- Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neckOsteoporosis International, 2009
- The relation between bisphosphonate use and non-union of fractures of the humerus in older adultsOsteoporosis International, 2008
- Variability in the Assessment of Fracture-Healing in Orthopaedic Trauma StudiesJournal of Bone and Joint Surgery, 2008
- Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case reportActa Orthopaedica, 2008
- Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapyJournal of Bone and Mineral Metabolism, 2007
- Subtrochanteric insufficiency fractures in patients on alendronate therapyThe Journal of Bone and Joint Surgery. British volume, 2007
- Upper humeral cortical thickness as an indicator of osteopenia: diagnostic significance in solitary myeloma of boneSkeletal Radiology, 1991